StockNews.com Initiates Coverage on Corbus Pharmaceuticals (

StockNews.com assumed coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. CRBP has been the topic of several other research reports. Oppenheimer raised Corbus Pharmaceuticals from a “market perform” rating to an […]

Related Keywords

, Corbus Pharmaceuticals Holdings Inc , Corbus Pharmaceuticals Trading , Corbus Pharmaceuticals , News Ratings For Corbus Pharmaceuticals Daily , Dimensional Fund Advisors , Vident Investment Advisory , Virtu Financial , Hedge Funds Weigh In On Corbus Pharmaceuticals , Get Rating , Point Capital Management , Sigma Investments , Fund Advisors , Investment Advisory , Pharmaceuticals Holdings , Corbus Pharmaceuticals Daily , Nasdaq Crbp , Crbp , Medical , Initiated Coverage , Stocknews Com ,